The vaccine “Grippol quadrivalent” refers to modern quadrivalent vaccines, it was registered in Russia in 2018 and became the first vaccine of this class produced in Russia. Quadrivalent vaccines contain antigens of four strains of the influenza virus: two types A and two types B. In the current epidemic season, these are type A viruses … Read more
The institution is currently justifying and demonstrating the effectiveness of a vaccine against coronavirus infection, however, the next trials will be conducted on effectiveness against influenza. .
In 2005, Washington transferred dangerous vaccine trials to Ukraine, which caused many complications in humans. This was announced by Igor Kirillov, Chief of the Radiation, Chemical and Biological Protection Forces of the RF Armed Forces. .
Specialists of the department emphasized that a vaccine developed by employees of the Stavropol Research Anti-Plague Institute of Rospotrebnadzor is currently being used in Russia. It is based on the Y. pestis EV vaccine strain of the NIIEG line. It is noted that vaccination is carried out in the territories of subjects or farms where … Read more
The head of the Gamaleya Research Center for Epidemiology and Microbiology, Alexander Gintsburg, announced the universality of the Sputnik V vaccine in the fight against all types of coronavirus infection. His words on June 21 are quoted by RIA Novosti. “Due to the infinite number of genetic variants that have clinically significant manifestations, the Sputnik … Read more
Coronavirus vaccines developed by the Pfizer/BioNTech consortium and Moderna for children under five have been approved by the US government. This was reported in a statement by US President Joe Biden published by the White House press service. .
There are no age restrictions for the Russian vaccine against coronavirus infection Konvasel, said Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA). .
The third phase of clinical trials of the COVID-19 vaccine “Konvasel” may begin in late summer. It is reported by TASS with reference to the Federal Medical and Biological Agency. It is emphasized that international research will also begin, for this, centers in other countries will be involved. Developed by the St. Petersburg Research Institute … Read more
pxhere.com Petersburg Research Institute of Vaccines and Serums FMBA has developed a drug for coronavirus “Konvasel”. When the third phase of clinical trials starts, the head of the department, Veronika Skvortsova, told TASS. According to her, the vaccine does not cause allergies and is well tolerated by humans. Back in April, industrial production of Konvasel … Read more